CTOs on the Move

Novitium Energy, A National Energy Partners Comp

www.novitiumenergy.com

 
Novitium Energy is a commercial solar development company that operates under National Energy Partners. The company specializes in providing turnkey renewable energy solutions throughout the United States. With over 40 years of combined experience, Novitium focuses on designing, financing, and managing solar projects for commercial clients, nonprofits, and educational institutions. Their services include the installation of commercial solar systems, such as carport, roof-mounted, and ground-mounted arrays. They offer full-service development, which encompasses feasibility analysis, financing, and ongoing monitoring. Novitium also provides financial solutions, guiding clients on federal tax credits and customized financing models to meet their energy efficiency and sustainability goals. ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Pampered Lawns Inc

Pampered Lawns Inc is a Houston, TX-based company in the Business Services sector.

Encore RPO

Encore RPO is a Simi Valley, CA-based company in the Business Services sector.

youtheory

Health and beauty starts with you, and ends with youtheory® Collagen | Turmeric | Resveratrol | Revive | Hyaluronic Acid | Maca Root | Sleep |

Bee Kalt Travel

Bee Kalt Travel is a Royal Oak, MI-based company in the Business Services sector.

Biocartis

Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.